DEXCOM INC (DXCM) Amortization of Intangible Assets USD 2021 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Dexcom Inc quarterly/annual Amortization of Intangible Assets history and growth rate from 2021 to 2023.
  • Dexcom Inc Amortization of Intangible Assets for the quarter ending December 31, 2023 was $2.9 M, a 61.1% increase year-over-year.
  • Dexcom Inc Amortization of Intangible Assets for the twelve months ending December 31, 2023 was $8.1 M, a 8% increase year-over-year.
  • Dexcom Inc annual Amortization of Intangible Assets for 2023 was $8.1 M, a 8% increase from 2022.
  • Dexcom Inc annual Amortization of Intangible Assets for 2022 was $7.5 M, a 103% increase from 2021.
  • Dexcom Inc annual Amortization of Intangible Assets for 2021 was $3.7 M, a 48% increase from 2020.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $8.1 M $2.9 M +$1.1 M +61.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-08
Q3 2023 $7 M $1.7 M -$100 K -5.56% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $7.1 M $1.7 M -$200 K -10.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $7.3 M $1.8 M -$200 K -10% Jan 1, 2023 Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $7.5 M $1.8 M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-08
Q3 2022 $1.8 M +$500 K +38.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-26
Q2 2022 $1.9 M +$1.4 M +280% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-27
Q1 2022 $2 M Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-27
Q3 2021 $1.3 M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-27
Q2 2021 $500 K Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.